Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -1.31 |
| peg ratio | 0.01 |
| price to book ratio | -2.37 |
| price to sales ratio | 17.86 |
| enterprise value multiple | -2.27 |
| price fair value | -2.37 |
profitability ratios | |
|---|---|
| gross profit margin | 85.02% |
| operating profit margin | -1096.02% |
| pretax profit margin | -1292.14% |
| net profit margin | -1292.14% |
| return on assets | -87.7% |
| return on equity | 211.43% |
| return on capital employed | -89.49% |
liquidity ratio | |
|---|---|
| current ratio | 5.73 |
| quick ratio | 5.68 |
| cash ratio | 5.13 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 288.57 |
| operating cycle | 581.07 |
| days of payables outstanding | 661.64 |
| cash conversion cycle | -80.57 |
| receivables turnover | 1.25 |
| payables turnover | 0.55 |
| inventory turnover | 1.26 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.46 |
| debt equity ratio | -0.94 |
| long term debt to capitalization | -15.44 |
| total debt to capitalization | -16.48 |
| interest coverage | -4.33 |
| cash flow to debt ratio | -1.40 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.83 |
| cash per share | 5.18 |
| operating cash flow per share | -3.82 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -1.40 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -520.23 |
Frequently Asked Questions
Phathom Pharmaceuticals, Inc. (PHAT) published its most recent earnings results on 07-11-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT)'s trailing twelve months ROE is 211.43%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Phathom Pharmaceuticals, Inc. (PHAT) currently has a ROA of -87.7%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
PHAT reported a profit margin of -1292.14% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.73 in the most recent quarter. The quick ratio stood at 5.68, with a Debt/Eq ratio of -0.94.